Klaus G. Larsen
Valby, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Benefits and safety of brexpiprazole in adolescents living with schizophrenia: a plain language summary.
Journal: Current medical research and opinion
Published: June 09, 2026
Fixed-Dose Brexpiprazole and Sertraline Combination Therapy for the Treatment of Posttraumatic Stress Disorder: A Phase 3, Randomized Trial.
Journal: Journal of clinical psychopharmacology
Published: February 28, 2025
Safety and Efficacy of Brexpiprazole in the Treatment of Irritability Associated with Autism Spectrum Disorder: An 8-Week, Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial and 26-Week Open-Label Extension in Children and Adolescents.
Journal: Journal of child and adolescent psychopharmacology
Published: February 19, 2025
Efficacy and safety of brexpiprazole in adolescents with schizophrenia: a multicountry, randomised, double-blind, placebo-controlled, phase 3 trial with an active reference.
Journal: The lancet. Psychiatry
Published: September 24, 2024
Defining a clinically meaningful within-patient change threshold for the Cohen-Mansfield Agitation Inventory in Alzheimer's dementia.
Journal: Frontiers in neurology
Published: March 04, 2024
Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: November 06, 2023
Effects of adjunctive brexpiprazole on patient life engagement in major depressive disorder: Post hoc analysis of Inventory of Depressive Symptomatology Self-Report data.
Journal: Journal of psychiatric research
Published: October 27, 2022
Assessment of patient life engagement in major depressive disorder using items from the Inventory of Depressive Symptomatology Self-Report (IDS-SR).
Journal: Journal of psychiatric research
Published: September 01, 2022
Are self-reported and self-monitored adherence good proxies for reaching relevant plasma concentrations?: Experiences from a study of anti-depressants in healthy volunteers.
Journal: Clinical trials (London, England)
Published: May 03, 2021
Patient Response Trajectories in Major Depressive Disorder.
Journal: Psychopharmacology bulletin
Published: October 05, 2020
Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study.
Journal: Neuropsychiatric disease and treatment
Published: February 26, 2019
Last Updated: 09/26/2026